Skip to main content

Advertisement

SpringerLink
Log in

If DILI Is Suspected, Don’t Dally

  • UNM CLINICAL CASE CONFERENCES
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Abugroun A, Garcia IC, Ahmed F, Potts S, et al. The first report of atovaquone/proguanil-induced vanishing bile duct syndrome: case report and mini-review. Travel Med Infect Dis. 2019;22:101439. https://doi.org/10.1016/j.tmaid.2019.06.010.

    Article  Google Scholar 

  2. Atovaquone. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.

    Google Scholar 

  3. Grieshaber M, Lämmli J, Marcus L. Acute hepatitis and atovaquone/proguanil. J Travel Med. 2005;12:289–290. https://doi.org/10.2310/7060.2005.12510.

    Article  PubMed  Google Scholar 

  4. Kimura M, Koga M, Kikuchi T, Miura T, Maruyama H. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group. Parasitol Int. 2012;61:466–469. https://doi.org/10.1016/j.parint.2012.03.004.

    Article  CAS  PubMed  Google Scholar 

  5. Beretta-Piccoli BT, Mieli-Vergani G, Bertoli R, Mazzucchelli L, et al. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun. 2017;1:293–298. https://doi.org/10.1002/hep4.1039.

    Article  CAS  Google Scholar 

  6. Wielgo-Polanin R, Lagarce L, Gautron E, Diquet B, et al. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil. Int J Antimicrob Agents. 2005;26:176–178.

    Article  CAS  Google Scholar 

  7. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015. https://doi.org/10.3390/ijms17010014.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rochon J, Protiva P, Seeff LB, Fontana RJ, et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology (Baltimore, MD). 2008;48:1175–1183. https://doi.org/10.1002/hep.22442.

    Article  PubMed Central  Google Scholar 

  9. Hayashi PH. Drug-induced liver injury network causality assessment: criteria and experience in the United States. Int J Mol Sci. 2016;17:201. https://doi.org/10.3390/ijms17020201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rockey DC, Seeff LB, Rochon J, Freston J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (Baltimore, MD). 2010;51:2117–2126. https://doi.org/10.1002/hep.23577.

    Article  PubMed Central  Google Scholar 

  11. Epstein LJ, Mohsenifar Z, Daar ES, Yeh V, et al. Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia. Am J Med Sci. 1994;308:5–8. https://doi.org/10.1097/00000441-199407000-00003.

    Article  CAS  PubMed  Google Scholar 

  12. White A, LaFon S, Rogers M, Andrews E, et al. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol Off Publ Int Retrovirol Assoc. 1995;9:280–285.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, University of New Mexico School of Medicine, MSC 10-5550, Albuquerque, NM, 87131, USA

    Aamer Abbass, Sameen Khalid, Neal Rakov & Denis McCarthy

  2. Division of Internal Medicine, Loyola Medicine-MacNeal Hospital, Chicago, IL, USA

    Umer Farooq

  3. Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA

    Joshua Hanson & David Martin

Authors
  1. Aamer Abbass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sameen Khalid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Umer Farooq
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neal Rakov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joshua Hanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Denis McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aamer Abbass.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abbass, A., Khalid, S., Farooq, U. et al. If DILI Is Suspected, Don’t Dally. Dig Dis Sci 66, 52–55 (2021). https://doi.org/10.1007/s10620-020-06730-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06730-4

Keywords

Search

Navigation